EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Lack of adverse long-term prognostic effect of aspirin therapy in patients treated with angiotensin converting enzyme inhibitors after myocardial infarction Results from a nationwide French registry of acute myocardial infarction



Lack of adverse long-term prognostic effect of aspirin therapy in patients treated with angiotensin converting enzyme inhibitors after myocardial infarction Results from a nationwide French registry of acute myocardial infarction



Journal of the American College of Cardiology 37(2 Supplement A): 274A, February




(PDF emailed within 1 workday: $29.90)

Accession: 035204033

Download citation: RISBibTeXText



Related references

ASS, Beta Blocker and angiotensin-converting enzyme inhibitors as an initial therapy for acute myocardial infarction Results from the Berlin Myocardial Infarction Registry. European Heart Journal 23(Abstract Supplement): 726, August-September, 2002

Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. American Journal of Cardiovascular Drugs 15(6): 439-449, 2016

Lack of long-term prognostic role of female gender after acute myocardial infarction One-year results of the Nationwide French Multicenter USIK Registry. Circulation 98(17 SUPPL ): I273-I274, Oct 27, 1998

Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry). American Journal of Cardiology 114(3): 329-335, 2014

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Journal of the American College of Cardiology 32(2): 360-367, 1998

Deleterious prognostic significance of low body mass index in patients with acute myocardial infarction One-year results from a nationwide French registry of acute myocardial infarction. Circulation 104(17 Supplement): II 698, October 23, 2001

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction registry and the Myocardial Infarction Registry. Journal of the American College of Cardiology 36(7): 2064-2071, December, 2000

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction (MITRA) registry and the Myocardial Infarction Registry (MIR). Journal of the American College of Cardiology 36(7): 2064-2071, 2000

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. Journal of the American College of Cardiology 35(7): 1801-1807, 2000

Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. American Journal of Cardiology 99(9): 1208-1211, 2007

Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. American Journal of Hypertension 12(7): 665-672, 1999

Are different angiotensin converting enzyme inhibitors identical for treatment of acute myocardial infarction? Results from the Hong-Kong post-myocardial infarction trial. European Heart Journal 20(ABSTR SUPPL ): 287, 1999

Lack of long-term prognostic significance of infarct-related artery patency at late angiography after acute myocardial infarction in medically-treated patients An incentive for early recanalization after myocardial infarction. European Heart Journal 18(ABSTR SUPPL ): 277, 1997

Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). Journal of Invasive Cardiology 13(5): 367-372, 2001

Long-term treatment with angiotensin-converting enzyme inhibitors, beta-blockers or a combination of angiotensin-converting enzyme inhibitors and beta-blockers in low-risk patients after acute myocardial infarction: The ABC study. HeartDrug 1(1): 20-25, January-February, 2001